Kentucky Retirement Systems Insurance Trust Fund Has $1.40 Million Holdings in Humana Inc. (NYSE:HUM)

Kentucky Retirement Systems Insurance Trust Fund lessened its stake in Humana Inc. (NYSE:HUM) by 8.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,033 shares of the insurance provider’s stock after selling 353 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Humana were worth $1,398,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Rakuten Securities Inc. acquired a new stake in shares of Humana in the 4th quarter valued at approximately $25,000. Gradient Investments LLC lifted its holdings in Humana by 200.0% during the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 40 shares during the last quarter. Cetera Trust Company N.A acquired a new stake in Humana during the 4th quarter valued at $28,000. Private Wealth Management Group LLC acquired a new stake in Humana during the 4th quarter valued at $32,000. Finally, Carolinas Wealth Consulting LLC lifted its holdings in Humana by 274.1% during the 4th quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after purchasing an additional 74 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Down 0.2 %

Shares of HUM stock traded down $0.61 during mid-day trading on Monday, reaching $392.02. 571,515 shares of the stock traded hands, compared to its average volume of 1,728,683. The stock’s fifty day simple moving average is $365.66 and its two-hundred day simple moving average is $347.02. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77. The company has a market cap of $47.24 billion, a price-to-earnings ratio of 24.39, a price-to-earnings-growth ratio of 2.27 and a beta of 0.51. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54.

Analysts Set New Price Targets

Several equities research analysts have issued reports on HUM shares. Truist Financial raised their price target on Humana from $355.00 to $400.00 and gave the company a “hold” rating in a report on Monday, July 15th. TD Cowen increased their price objective on Humana from $396.00 to $407.00 and gave the stock a “buy” rating in a research report on Wednesday, July 24th. Jefferies Financial Group lowered their price objective on Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a research report on Monday, April 22nd. Oppenheimer lowered their price objective on Humana from $415.00 to $370.00 and set an “outperform” rating on the stock in a research report on Thursday, April 25th. Finally, Royal Bank of Canada lowered their price objective on Humana from $415.00 to $353.00 and set an “outperform” rating on the stock in a research report on Thursday, April 25th. Fourteen analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and an average target price of $402.60.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.